About Provox Technologies Corporation
Provox Technologies Corporation is the leading producer of voice recognition documentation software for healthcare providers. TalkNotes interfaces with various practice management billing systems and creates an intuitive electronic medical chart.
Latest Provox Technologies Corporation News
Mar 23, 2013
Apple Glen Bressner from Mid-Atlantic Venture Funds is a member of FundingPost online! Venture Fund Member Profile Share This Profile: The Mid-Atlantic Venture Funds are four private venture capital partnerships (the first two were called NEPA Venture Funds) with approximately $200 million under management.Our primary investment interest is in purchasing the equity securities of new, young or growing businesses located in the Mid-Atlantic, although we can invest elsewhere, and have.Our investment capital has been provided by approximately 75 leading (mostly Mid-Atlantic-based) institutions and individuals. Nine principals of the general partners are either veteran venture capitalists or successful entrepreneurs. Glen Bressner Partner Mid-Atlantic Venture Funds Glen Bressner has been a partner with the Mid-Atlantic Venture Funds since its founding in 1985. The firm presently manages four venture capital partnerships and maintains offices in Bethlehem, PA, and Reston, Virginia. Upon completing his MBA, he began his career as a venture capitalist when he joined Key Venture Capital Corporation, a small business investment company, and opened its Boston office in 1984. He holds a BSBA, cum laude from Boston University and an MBA from Babson College. As Chairman of the Greater Philadelphia Venture Group in 1996-1997, Glen conceived and organized the first GPVG Venture Institute. He was responsible for MAVF investments in International Quantum Epitaxy (LSE: IQE plc), Innovative Solutions & Support (NASDAQ: ISSC), Access Health Marketing (NASDAQ: ACCS, acquired by HBO and Company), Axeda (NASDAQ: XEDA, formerly Ravisent Technologies, AnyTime Access (acquired by Digital Insight (NASDAQ: DGIN), UltraCision (acquired by Johnson & Johnson) and MicroE Systems. Representative Investments Provox Technologies Corporation Producer of voice recognition documentation software for healthcare providers. Provox's product, TalkNotes, interfaces with various practice management billing systems and creates an intuitive electronic medical chart. Storeroom Solutions Provides professional management of the maintenance, repair and operating supplies in the storerooms (spare parts rooms) of industrial plants. MicroE Systems Develops, manufactures and markets optical encoding technology for the precision positioning and measurement industries. CorePROFIT Solutions Simplifies the process of acquiring, calculating, interpreting and employing enterprise profitability information. Glen participated in the FundingPost event: PA Venture Capital Showcaseon Wed., May 7, 2008 in PA, Sponsored by Wolf Block To list your Company on our website and make your profile available to Glen and 7,500+ other VCs and Angel Investors, Click Here. About FundingPost For over Fourteen Years FundingPost has worked with thousandsof Angel and Venture Capital Investors. We believe that it isimportant to reach investors in every medium possible -both online and offline. We have been directly responsible fortons of success stories and Millions and Millions of dollars raised.We look forward to introducing your company to the leading Venture and Angel Investors nationwide. Sign up now: Entrepreneurs / Investors Join the FundingPost email list and learn how, when and where you can meet these Investors: Other Venture Profiles:
Provox Technologies Corporation Frequently Asked Questions (FAQ)
Where is Provox Technologies Corporation's headquarters?
Provox Technologies Corporation's headquarters is located at 2965 Colonnade Drive, SW, Roanoke.
What is Provox Technologies Corporation's latest funding round?
Provox Technologies Corporation's latest funding round is Acquired.
How much did Provox Technologies Corporation raise?
Provox Technologies Corporation raised a total of $10.6M.
Who are the investors of Provox Technologies Corporation?
Investors of Provox Technologies Corporation include Atirix Medical Systems, Gryphon Investors, Monument Capital Partners, MRW Capital, ECentury Capital and 6 more.
Who are Provox Technologies Corporation's competitors?
Competitors of Provox Technologies Corporation include Implantable Provider Group, athenahealth, ArisGlobal, InstaMed, PHT Corporation and 7 more.
Compare Provox Technologies Corporation to Competitors
athenahealth focuses on providing cloud-based healthcare products and services, operating in the healthcare technology sector. It offers a range of services including electronic health records, revenue cycle services, patient engagement tools, population health services, telehealth services, and platform services. These services aim to improve clinical efficiency, patient relationships, care coordination, and financial performance in healthcare settings. The company was founded in 1997 and is based in Watertown, Massachusetts.
Endovasix is a developer of a proprietary technology used to treat acute cerebral arterial clots that cause strokes. Its initial offering is a technology that breaks apart an acute clot in a more effective fashion than thrombolytic drugs, and that can be used adjunctively with a wide array of interventional cardiology and radiology procedures. The target market includes Vascular Neurologists, Interventional Radiologists, NeuroRadiologists, and Cardiologists and Endovascular Surgeons and Neurosurgeons who treat patients who have experienced an occlusive stroke, coronary artery disease, or a peripheral stroke.
Chiral Quest is a company that specializes in the development and production of intermediates for the pharmaceutical industry. The company's main offerings include the provision of research and production services for intermediates, RSMs, and GMP intermediates, utilizing their unique catalysts and world-class asymmetric hydrogenation technology. Chiral Quest primarily serves the global pharmaceutical industry. It was founded in 2000 and is based in Monmouth Junction, New Jersey.
NCI Cancer Hospital is a private oncology centre in Malaysia that combines treatment and clinical research. NCI aims to provide a range of services from diagnosis, laboratory analysis, surgery, chemotherapy and radiotherapy. It operates to GCP and has conducted clinical trials for a number of pharmaceutical companies including Roche, BMS and AstraZeneca.
Norton Audits aims to provide clinical trial monitoring, auditing, and training.
GI Alliance is a company that focuses on gastroenterology, operating within the healthcare industry. The company offers a range of services for adult and pediatric gastrointestinal health, including colon cancer screening, telehealth visits, chronic care management, infusion therapy, and colorectal surgery. It was founded in 2018 and is based in Southlake, Texas.